Stocks’ immediate moves after earnings reports tend to depend on how the numbers compare with analysts’ expectations. With second-quarter earnings seasons getting started, you might be wondering how companies’ financials will stack up against analysts’ Read more…
Boeing delivered 51 passenger and cargo planes in June, its best month since March 2019 when a second 737 MAX crash grounded that plane model for a year-and-a-half. Boeing (BA) – Get The Boeing Company Read more…
The cruise lines Carnival and Royal Caribbean have been moving to solve something that has caused major issues for passengers. The cruise industry has faced a perfect storm (so to speak) as it has operated Read more…
Hackers are prepared to prey on shoppers hoping to nab a good deal on Amazon’s two Prime days. Amazon (AMZN) – Get Amazon.com Inc. Report Prime’s iconic two shopping days kicked off on Tuesday, giving cyber Read more…
Americans are saving around $140 million a day as gas prices extend their longest losing streak in two years amid a sharp pullback in global crude markets. U.S. oil prices fell to the lowest levels Read more…
The U.S. Treasury sold $33 billion in 10-year notes Tuesday at a high auction yield of 2.96%, but fading demand from foreign buyers ahead of tomorrow’s key June inflation reading made for a messy benchmark Read more…
Target stock has slumped this year, nearly halved from the high. Is now the time to buy? This has not been a good year for many stocks, but the bulls are particularly taken aback by Read more…
Healthier options are becoming more popular at the coffeehouse. Despite the fact that retail coffee prices keep on rising, some people still won’t forego their daily trip to Dunkin’ (DNKN) – Get Dunkin’ Brands Group, Read more…
The lungs have evolved to keep things out. Can these biotech stocks get drugs in? You inhale and exhale over 20,000 times per day. Air, dust, pollen, and millions of bacteria and viruses. Thankfully, 3 Read more…
Wood’s flagship Ark Innovation ETF has fallen 54% this year, as her technology companies have stumbled. Renowned investor Cathie Wood, chief executive of Ark Investment Management, on Monday purchased a heavy dose of biotechnology stocks. Read more…